missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Human LAR (NP_569707) VersaClone cDNA

R&D Systems™ Human LAR (NP_569707) VersaClone cDNA is a member of the protein tyrosine phosphatase (PTP) family.

Brand:  R&D Systems™ RDC2115

Product Code. 18719198

  • 12105.00 SEK / 10µg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

The Human LAR (NP_569707) VersaClone cDNA clone contains the complete ORF for LAR/PTPRF, along with a Kozak consensus sequence for optimal translation initiation. The gene insert is flanked with convenient multiple cloning sites which can be used to easily cut and transfer the gene cassette into your desired expression vector. The LAR/PTPRF insert is sequence verified and the entire plasmid DNA and insert translated sequences are provided.
Specifications

Specifications

LAR/PTPRF
10 μg at 0.2 μg/μL
5710bp
5792
Store the unopened product at -20°C to -70°C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
10 μg
NP_569707
cDNA is provided in 10 mM Tris-Cl
8.5
LCA-homolog, protein tyrosine phosphatase, receptor type, F, PTPRF, receptor type, F polypeptide, receptor-linked protein-tyrosine phosphatase LAR, receptor-type tyrosine-protein phosphatase F
Human
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.